Downregulation of Chemokine CCL20 Involved in Myeloma Cells Resistant to Elotuzumab and Lenalidomide

OBJECTIVE: Few studies have focused on investigating resistance mechanisms in myeloma immunotherapy. This study aimed to explore the relevant factor involved in the resistance of Elotuzumab and lenalidomide. METHODS: Cell models which are resistant to Elotuzumab and lenalidomide were constructed; di...

Full description

Saved in:
Bibliographic Details
Published in:Onco Targets Ther
Main Authors: Wang, Huihan, Shi, Hua, He, Xiaowei, Liao, Aijun
Format: Artigo
Language:Inglês
Published: Dove 2021
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8071208/
https://ncbi.nlm.nih.gov/pubmed/33907421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S300328
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items